ロード中...
LSD1 as a Biomarker and the Outcome of Its Inhibitors in the Clinical Trial: The Therapy Opportunity in Tumor
Tumors are the foremost cause of death worldwide. As a result of that, there has been a significant enhancement in the investigation, treatment methods, and good maintenance practices on cancer. However, the sensitivity and specificity of a lot of tumor biomarkers are not adequate. Hence, it is of i...
保存先:
| 出版年: | J Oncol |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Hindawi
2021
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8018836/ https://ncbi.nlm.nih.gov/pubmed/33833800 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2021/5512524 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|